Ensign Peak Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $540K | Hold |
63,735
| – | – | ﹤0.01% | 1534 |
|
|
2025
Q1 | $512K | Hold |
63,735
| – | – | ﹤0.01% | 1543 |
|
|
2024
Q4 | $572K | Hold |
63,735
| – | – | ﹤0.01% | 1559 |
|
|
2024
Q3 | $467K | Hold |
63,735
| – | – | ﹤0.01% | 1627 |
|
|
2024
Q2 | $364K | Hold |
63,735
| – | – | ﹤0.01% | 1665 |
|
|
2024
Q1 | $319K | Sell |
63,735
-3,215
| -5% | -$16.1K | ﹤0.01% | 1685 |
|
|
2023
Q4 | $602K | Buy |
66,950
+17,850
| +36% | +$160K | ﹤0.01% | 1620 |
|
|
2023
Q3 | $382K | Buy |
49,100
+13,650
| +39% | +$106K | ﹤0.01% | 1652 |
|
|
2023
Q2 | $343K | Buy |
+35,450
| New | +$343K | ﹤0.01% | 1698 |
|
|
2022
Q4 | – | Sell |
-40,150
| Closed | -$302K | – | 1822 |
|
|
2022
Q3 | $302K | Buy |
40,150
+7,440
| +23% | +$56K | ﹤0.01% | 1704 |
|
|
2022
Q2 | $329K | Hold |
32,710
| – | – | ﹤0.01% | 1636 |
|
|
2022
Q1 | $405K | Buy |
32,710
+1,640
| +5% | +$20.3K | ﹤0.01% | 1642 |
|
|
2021
Q4 | $711K | Sell |
31,070
-100,133
| -76% | -$2.29M | ﹤0.01% | 1453 |
|
|
2021
Q3 | $2.9M | Sell |
131,203
-20,396
| -13% | -$451K | 0.01% | 903 |
|
|
2021
Q2 | $1.97M | Buy |
151,599
+50,540
| +50% | +$655K | ﹤0.01% | 1144 |
|
|
2021
Q1 | $1.31M | Buy |
101,059
+7,702
| +8% | +$100K | ﹤0.01% | 1309 |
|
|
2020
Q4 | $1.29M | Buy |
93,357
+24,832
| +36% | +$343K | ﹤0.01% | 1286 |
|
|
2020
Q3 | $1.01M | Buy |
68,525
+52,872
| +338% | +$779K | ﹤0.01% | 1309 |
|
|
2020
Q2 | $254K | Buy |
+15,653
| New | +$254K | ﹤0.01% | 1559 |
|